The ability to establish a large database of human health data is key for the personalised nutrition sector to flourish, says the co-founder of HEM Pharma – a South Korean start-up which counts industry big names, including Amway, Amorepacific, CJ Cheiljedang, and COSMAX-NBT, as its investors.